Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Hyperprolactinaemia (raised prolactin, galactorrhoea)

Endocrinology and metabolism · Abnormal laboratory result · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: Cause of 20 to 25% of secondary amenorrhoea [1]

Raised prolactin: confirm and look for the cause

Laboratory tests (repeat, at rest, if possible in another laboratory)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

On an antipsychotic or another drug raising prolactin

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (9)
  1. Brue T, Delemer B, et le groupe de travail de la Société française d'endocrinologie. Diagnostic et prise en charge des hyperprolactinémies. Consensus d'experts de la SFE (congrès de Strasbourg, octobre 2005). Médecine Clinique Endocrinologie & Diabète, hors-série, septembre 2006. Version publiée : Brue T, Delemer B. Diagnosis and management of hyperprolactinemia: expert consensus - French Society of Endocrinology. Ann Endocrinol (Paris). 2007;68(1):58-64.
  2. Huang W, Molitch ME. Evaluation and management of galactorrhea. Am Fam Physician. 2012;85(11):1073-1080.
  3. Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023;19(12):722-40.
  4. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A, et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab. 2002;87(2):581-8.
  5. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 0343 (prolactine), 0884 (séparation chromatographique des formes moléculaires de la prolactine) et 7402 (hCG sanguine).
  6. National Institute for Health and Care Excellence (NICE, Royaume-Uni). Fertility problems: assessment and treatment. NICE guideline NG257, 31 mars 2026 (remplace CG156).
  7. Glezer A, Mendes Garmes H, Kasuki L, Martins M, et al. Diagnosis of hyperprolactinemia in women: a position statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM). Arch Endocrinol Metab. 2024;68:e230502.
  8. National Institute for Health and Care Excellence (NICE, Royaume-Uni). Psychosis and schizophrenia in adults: prevention and management. Clinical guideline CG178, 12 février 2014, dernière mise à jour le 4 septembre 2026.
  9. Kim HR, Kim SM, Kang WS, Jeon HJ, Jang SH, Jon DI, et al. Development of a guideline for antipsychotic-induced hyperprolactinemia in Korea using the ADAPTE process. Clin Psychopharmacol Neurosci. 2023;21(3):447-456.